Somerville Kurt F Lowers Holdings in Roche Holding AG (OTCMKTS:RHHBY)

Somerville Kurt F cut its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 32.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,794 shares of the company’s stock after selling 4,790 shares during the period. Somerville Kurt F’s holdings in Roche were worth $342,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brooklyn Investment Group increased its stake in shares of Roche by 36.6% in the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after acquiring an additional 363 shares during the period. IHT Wealth Management LLC purchased a new position in Roche during the third quarter valued at $236,000. Verity Asset Management Inc. grew its position in shares of Roche by 26.8% in the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock valued at $280,000 after purchasing an additional 1,697 shares during the period. HighPoint Advisor Group LLC raised its position in shares of Roche by 2.8% during the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock worth $387,000 after purchasing an additional 304 shares during the last quarter. Finally, Confluence Investment Management LLC lifted its stake in Roche by 26.3% in the 4th quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after buying an additional 2,910 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Morgan Stanley began coverage on shares of Roche in a research report on Wednesday, February 12th. They issued an “equal weight” rating for the company. UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. Finally, Sanford C. Bernstein raised shares of Roche to a “strong-buy” rating in a report on Thursday, January 30th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Roche Stock Up 1.7 %

Shares of RHHBY opened at $40.02 on Friday. Roche Holding AG has a 12-month low of $29.20 and a 12-month high of $44.31. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. The company’s 50-day moving average price is $41.41 and its 200 day moving average price is $38.73.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.